| scholarly article | Q13442814 |
| P2093 | author name string | Dormandy TL | |
| Dormandy JA | |||
| Hoare E | |||
| Colley J | |||
| Arrowsmith DE | |||
| P2860 | cites work | Aging: a theory based on free radical and radiation chemistry | Q27860549 |
| An evaluation of the heat precipitation method for plasma fibrinogen estimation | Q36632977 | ||
| Lipid peroxidation: its measurement, occurrence, and significance in animal tissues | Q40049496 | ||
| A lipid and lipoprotein study of patients with peripheral arterial disease, using micro-nephelometry | Q43496743 | ||
| High blood viscosity: An aetiological factor in venous thrombosis | Q48007762 | ||
| Simultaneous Flow and Pressure Measurements in Intermittent Claudication | Q52734253 | ||
| Diagnosis and classification of abnormal lipoprotein patterns | Q53003884 | ||
| Comparison of membrane filtration and nephelometry with analytical ultracentrifugation, for the quantitative analysis of low density lipoprotein fractions | Q53005711 | ||
| “Viscosity-plus” Effect in Whole Blood at High Shear Rates | Q54410352 | ||
| Influence of Blood Viscosity on Blood Flow and the Effect of Low Molecular Weight Dextran | Q54996466 | ||
| The Susceptibility to Autoxidation of Human Red Cell Lipids in Health and Disease | Q69403325 | ||
| Stress arteriography | Q69998133 | ||
| Biological rancidification | Q70117711 | ||
| Estimation of serum total lipids | Q70388549 | ||
| Improved accuracy in automated fluorometric determination of plasma triglycerides | Q71488547 | ||
| Automated colorimetric method for estimating serum triglycerides | Q71836152 | ||
| The effect of increased fibrinogen content on the viscosity of blood | Q72385914 | ||
| Components in blood viscosity. The relative contribution of haematocrit, plasma fibrinogen and other proteins | Q72783454 | ||
| A rapid method of estimating fibrinogen | Q74032284 | ||
| Serum lipids and lipoproteins in peripheral vascular disease | Q93712895 | ||
| Fat transport in lipoproteins--an integrated approach to mechanisms and disorders | Q93837002 | ||
| P433 | issue | 5892 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | patient | Q181600 |
| rheology | Q271707 | ||
| hemodynamics | Q1642137 | ||
| claudication | Q2888709 | ||
| P304 | page(s) | 576-581 | |
| P577 | publication date | 1973-12-01 | |
| P1433 | published in | The BMJ | Q546003 |
| P1476 | title | Clinical, haemodynamic, rheological, and biochemical findings in 126 patients with intermittent claudication | |
| P478 | volume | 4 |
| Q41476926 | Action of Cinnarizine on the Hyperviscosity of Blood in Patients with Peripheral Obliterative Arterial Disease |
| Q42700608 | Action of cinnarizine on the hyperviscosity of blood in patients with peripheral obliterative arterial disease |
| Q69850239 | Allopurinol prevents ischaemia-dependent haemorheological changes |
| Q39845793 | Antibody-mediated tissue damage. Hyperviscosity and other complications of paraproteinaemia |
| Q29616762 | Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction |
| Q34555892 | Beneficial effect of fish oil on blood viscosity in peripheral vascular disease |
| Q44235869 | Blood Rheology and Cardiovascular Risk Factors in Type 1 Diabetes: Relationship with Microalbuminuria |
| Q40288209 | Blood rheology |
| Q39697000 | Blood rheology in general medicine and surgery |
| Q61831670 | Blood viscosity in young male diabetics with and without retinopathy |
| Q51555760 | Blood viscosity, plasma adrenaline and fasting insulin in hypertensive patients with left ventricular hypertrophy. ICARUS, a LIFE Substudy. Insulin CARotids US Scandinavica. |
| Q39459144 | Blood viscosity, red-cell flexibility, haematocrit, and plasma-fibrinogen in patients with angina |
| Q41601840 | Calf blood flow and systolic blood pressure in patients with hyperviscosity of the blood |
| Q34981446 | Can drug therapy alter the natural course of peripheral vascular disease?: a review |
| Q39563497 | Can drugs help patients with lower limb ischaemia? |
| Q67024768 | Changes in the blood rheology and their influence on the oxygen diffusion in normal and pathological pregnancies (author's transl) |
| Q42700593 | Cinnarizine in the treatment of peripheral vascular disease: mechanisms related to its clinical action |
| Q39717843 | Controlled Defibrination in the Treatment of Peripheral Vascular Disease |
| Q36756073 | Coronary artery disease and haemostatic variables in heterozygous familial hypercholesterolaemia |
| Q72767189 | Current Therapy for Intermittent Claudication |
| Q67232489 | Determination of lower leg blood flow in man by thermodilution |
| Q70353317 | Does oxpentifylline (‘Trental’) have a place in the treatment of intermittent claudication? |
| Q54215867 | Effect of clofibrate on blood viscosity in intermittent claudication. |
| Q69565321 | Effect of ketanserin on macrocirculatory and microcirculatory blood flow in patients with intermittent claudication. A prospective randomized study |
| Q44355000 | Effect of physical training on blood flow properties in patients with intermittent claudication |
| Q34748887 | Effect of venesection on calf blood flow in polycythaemia |
| Q50713297 | Effect on hematologic risk factors for coronary heart disease of a cholesterol reducing diet. |
| Q44987434 | Effects and limitations of pentoxifylline therapy in various stages of peripheral vascular disease of the lower extremity |
| Q34708941 | Effects of Flunarizine and Pentoxifylline on Walking Distance and Blood Rheology in Claudication |
| Q38187356 | Endothelial shear stress and blood viscosity in peripheral arterial disease |
| Q34489552 | Epidemiological characteristics of platelet aggregability. |
| Q39567249 | Epidemiology of atherosclerotic arterial disease in the lower limbs |
| Q36390027 | Erythrocyte deformability in peripheral occlusive arterial disease |
| Q36807345 | Ethnic group comparisons of variables associated with ischaemic heart disease |
| Q45043677 | Expansion of contracted visual fields following treatment with pentoxifylline in two patients with coexistent peripheral vascular disease--case reports |
| Q41740343 | Experimental models of chronic lower extremity arterial occlusive disease: lessons for drug development |
| Q43162739 | Fibrinogen |
| Q40409553 | Fibrinogen and markers of fibrinolysis and endothelial damage following resolution of critical limb ischaemia |
| Q47363812 | Fibrinogen in obesity before and after weight reduction |
| Q33612628 | Fibrinogen in relation to personal history of prevalent hypertension, diabetes, stroke, intermittent claudication, coronary heart disease, and family history: the Scottish Heart Health Study |
| Q50907848 | Fibrinogen is an independent marker for thoracic aortic atherosclerosis. |
| Q34488611 | Fibrinogen: a possible link between social class and coronary heart disease |
| Q40744822 | Fibrinogen: an important risk factor for atherothrombotic diseases |
| Q40725303 | Fibrinogen: its emerging role as a cardiovascular risk factor |
| Q68603148 | Fish oil supplementation in patients with stable claudication |
| Q54263968 | Haematocrit in patients attending a hypertension clinic. |
| Q39338214 | Haematological stress syndrome in atherosclerosis |
| Q55450666 | Haemoglobin, Smoking and Peripheral Vascular Disease |
| Q40582669 | Haemostatic function, arterial disease and the prevention of arterial thrombosis |
| Q58275954 | High blood hemoglobin concentration as risk factor of major atherosclerotic cardiovascular events in 114,159 healthy men and women in the Apolipoprotein MOrtality RISk study (AMORIS) |
| Q41245378 | Hyperfibrinogenaemia and hyperviscosity in sickle-cell crisis |
| Q46603801 | Increased cardiac output and microvascular blood flow during mild hemoconcentration in hamster window model |
| Q41592427 | Increased platelet aggregates in vascular and non-vascular illness: Correlation with plasma fibrinogen and effect of ancrod |
| Q41635547 | Influence of fibrinogen on cardiovascular disease |
| Q55429194 | Intermittent claudication: prevalence and risk factors |
| Q39523976 | Intravenous pentoxifylline in the treatment of rest pain: a preliminary report |
| Q39319104 | Letter: Hyperviscosity angina |
| Q41208114 | Markers of disease severity in peripheral atherosclerosis |
| Q45067609 | Measurement of blood viscosity using a conicylindrical viscometer |
| Q67232728 | Non-surgical management of peripheral vascular disease: a review |
| Q67888962 | Pentoxifylline in arterial disease of the legs |
| Q34173602 | Pentoxifylline. A review of its pharmacodynamic and pharmacokinetic properties, and its therapeutic efficacy |
| Q41560071 | Pharmacological approaches and strategies for therapeutic modulation of fibrinogen |
| Q36167879 | Pharmacological approaches to the treatment of intermittent claudication |
| Q39801249 | Physiopathology and Pharmacotherapy of Occlusive Arterial Disorders |
| Q39492304 | Platelet inhibition with Ticlopidine in atherosclerotic intermittent claudication |
| Q64954769 | Prognostic Significance of Rheological and Biochemical Findings in Patients with Intermittent Claudication |
| Q36596437 | Re-evaluation of heat precipitation method for plasma fibrinogen estimation: effect of abnormal proteins and plasma viscosity |
| Q54965703 | Relation between extent of coronary artery disease and blood viscosity. |
| Q45139381 | Results of Ankle Systolic Pressure Measurements in Patients With Intermittent Claudication Being Treated With Clofibrate |
| Q71467703 | Role of red cell sorbitol as determinant of reduced erythrocyte filtrability in insulin-dependent diabetics |
| Q85134599 | Second European Conference on Clinical Haemorheology |
| Q69865004 | Severe retinopathy and mild carbohydrate intolerance: possible role of insulin deficiency and elevated circulating growth hormone |
| Q71813755 | Significance of hemorrheology in the management of the ischemic limb |
| Q47762914 | Smoking, hemorheologic factors, and progression of peripheral arterial disease in patients with claudication |
| Q28244018 | Specific calcium antagonists in the treatment of peripheral vascular disease |
| Q46445578 | Subcutaneous Ancrod Therapy in Peripheral Arterial Disease: Improvement in Blood Viscosity and Nutritional Blood Flow |
| Q41145831 | The Protective Effects of Tirilated Mesylate (U74006F) on Ischemic and Reperfusion-Induced Cochlear Damage |
| Q41075034 | The Rheological Effects of Cinnarizine and Flunarizine in Normal and Pathologic Conditions |
| Q40755929 | The effect of oxpentifylline (Trental') on fibrinolytic activity and plasma fibrinogen levels |
| Q54337537 | The effects of age and cigarette-smoking on blood and plasma viscosity in men. |
| Q34516379 | The effects of intravenous isoxsuprine on blood viscosity in patients with occlusive peripheral arterial disease |
| Q39438260 | The great circulatory paradox |
| Q51665301 | The importance of plasma lipid, glucose, insulin and fibrinogen in femoropopliteal surgery |
| Q71813751 | The natural history of chronic leg ischemia |
| Q36331473 | The possible role of hemorheology in atherothrombogenesis |
| Q67232593 | The skin microcirculation and the pathogenesis of ischaemic necrosis and gangrene |
| Q42584252 | Therapeutic potentials of pentoxifylline for treatment of cardiovascular diseases. |
| Q69802275 | Thiobarbituric acid-reacting substances derived from autoxidizing linoleic and linolenic acids |
| Q40949204 | Treatment of severe foot ischaemia by defibrination with ancrod: A randomized blind study |
| Q92716085 | Usefulness of Haemoglobin Level Combined with CAMI-STEMI Score for Predicting MACCE in Patients with Acute ST-Elevation Myocardial Infarction after PCI |
| Q39659684 | Viscosimetric effect of fibrinogen |
| Q50951969 | Whole blood viscosity, blood pressure and cardiovascular risk factors in healthy blood donors. |
Search more.